首页> 外国专利> 'fabrication of biodegradable vaginal ring for combine contraceptive therapy of ethinyl estradiol and levonorgesterel'

'fabrication of biodegradable vaginal ring for combine contraceptive therapy of ethinyl estradiol and levonorgesterel'

机译:“制造可生物降解的阴道环,用于乙炔雌二醇和左炔诺孕酮的联合避孕治疗”

摘要

"FABRICATION OF BIODEGRADABLE VAGINAL RING FOR COMBINED CONTRACEPTIVE THERAPY OF ETHINYL ESTRADIOL AND LEVONORGESTREL" The aim of the present investigation was to fabricate and evaluate biodegradable vaginal ring for contraceptive therapy of ethinyl estradiol (EE) and levonorgesrel (LNG). Biodegradable intravaginal rings for contraceptive drug delivery present the potential of an easily adhered to women controlled and environment friendly method for contraception and hormone replacement. Fourier transform infrared spectroscopy (FTIR) had employed to study drug-drug and drugs-excipients incompatibility. Analytical method was developed by UV spectrophotometer using Q-Absorbance method. Vaginal ring of EE and LNG was successfully prepared with EE, LNG, polyurethane and polyethylene glycol by injection molding method and evaluated for tensile strength, percent elongation, percent compression, drug content, in-vitro drug release study, sterility testing and stability study. Optimization of process parameter was done by 3 factorial design using Design Expert software. Drug and excipients were found to be compatible to each other which were confirmed by FTIR study. Differential Scanning Calorimetry (DSC) study indicated that both drugs were found to be stable at 120 °C. Tensile strength, percent elongation and percent compression were found to be show good mechanical property of vaginal ring. In-vitro drug release of EE and LNG were found to be good for optimized batch up to 21 days. Sterility test suggested that the developed vaginal ring shows no microbial growth. Stability study shows vaginal ring containing EE and LNG were stable at accelerated condition. The present study demonstrated that, a vaginal ring is suitable for contraception and hold great potential for hormone replacement therapy. Keywords: Ethinyl Estradiol; Levonorgestrel; Contraception; Vaginal Ring; Controlled Release; 3 Factorial Design; Injection Molding.
机译:“用于乙炔雌二醇和左炔诺孕酮的联合避孕治疗的可生物分解的阴道环的制造”本研究的目的是制造和评估可生物降解的阴道环,用于乙炔雌二醇(EE)和左炔诺孕酮(LNG)的避孕治疗。用于避孕药物输送的可生物降解的阴道内环具有易于坚持使用受妇女控制和环境友好的避孕和激素替代方法的潜力。傅里叶变换红外光谱(FTIR)用于研究药物与药物-赋形剂的不相容性。紫外分光光度计采用Q-吸光度法开发了分析方法。用注射成型法成功地用EE,LNG,聚氨酯和聚乙二醇制备了EE和LNG的阴道环,并进行了拉伸强度,伸长率,压缩率,药物含量,体外药物释放研究,无菌测试和稳定性研究的评估。使用Design Expert软件通过三阶设计完成了工艺参数的优化。 FTIR研究证实药物和赋形剂彼此相容。差示扫描量热法(DSC)研究表明,两种药物均在120°C时稳定。发现拉伸强度,百分伸长率和百分压缩率显示出良好的阴道环机械性能。 EE和LNG的体外药物释放对于长达21天的优化批次非常有用。无菌测试表明,发达的阴道环未显示微生物生长。稳定性研究表明,含有EE和LNG的阴道环在加速状态下是稳定的。本研究表明,阴道环适用于避孕,具有巨大的激素替代疗法潜力。关键字:乙炔雌二醇;左炔诺孕酮;避孕;阴道环控释; 3析因设计;注塑成型。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号